FHND-6091

N/A

Report date: 2024/12/09 14:12:05
NME

Base Information

Drug NameFHND-6091
Drug Alias NameFHND-6091
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsSolid tumoursLupus Erythematosus, SystemicMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Chia Tai Fenghai Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Chia Tai Fenghai Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLupus Erythematosus, SystemicMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A